ftInvstr
TAKE · Healthcare ₹12.97 -1.52% Mkt Cap ₹189 Cr
← Search another stock

TAKE

Healthcare Biotechnology
★ Watchlist ⧉ Add to bucket
₹12.97
-1.52% today · 30d -2.85%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for TAKE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹30 Cr
NET PROFIT
₹1 Cr
OPM
3.35%
+1791.16pp YoY
EPS
₹0.07
PE 32.54
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-2.2% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
TAKE32.5419.0
BIOCON175.486.88
ANTHEM87.931.1
ONESOURCE—4.57
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
39
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation FAIR 40
Growth DECLINING 24
Profitability DECENT 55
Technicals WEAK 40
Risk LOW 70
Key Stats
TTM PE
32.54
P/B
6.15
52W HIGH
₹50.14
OFF HIGH
-74.13%
DIV YIELD
0.0%
MKT CAP
₹189 Cr
◉ Active Signals
MACDNeutral0.4479
RSI(14)Neutral54.55
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold TAKE and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.